DexCom price target raised to $84 from $77 at Citi

Finviz2026/03/11 10:03

By:Finviz

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Citi analyst Joanne Wuensch raised the firm’s price target on DexCom (DXCM) to $84 from $77 and keeps a Buy rating on the shares. The firm adjusted targets in the medical technology group post the Q4 reports. Sector fundamentals remain “healthy” despite the recent volatility, the analyst tells investors in a research note. Citi’s top picks are iRhythm and Medtronic.

Claim 70% Off TipRanks Premium

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Published first on – the ultimate source for real-time, market-moving breaking financial news.

See the top stocks recommended by analysts >>

Read More on DXCM:

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

DexCom price target raised to $84 from $77 at Citi

Claim 70% Off TipRanks Premium

You may also like

Trending news

Crypto prices